Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Sep 18 2024

Full Issue

Perspectives: Every Presidential Candidate Should Prioritize Affordable Prescriptions; It's Time To Reform 340B

Read recent commentary about pharmaceutical issues.

For many Americans, their confidence in the future of U.S. healthcare is low and their insecurity due to the cost of medicine is high. (Grace Han, 9/13)

On August 8, Benjamin Oldfield, MD, posted an opinion about the need to stand up against Big Pharma’s war on health centers.  I would like to address a different perspective on the issue, and how it affects patients in Connecticut. (Dawn Holcombe, 9/17)

Health insurance premiums are a direct reflection of the cost of health care goods and services. Over two dozen state reports have found that the prices hospitals and doctors charge along with the cost of prescription drugs are the key drivers of high health care premiums. (Lora Pellegrini, 9/14)

PBM profits have exploded from $6.3 billion in 2012 to $27.6 billion in 2022. Meanwhile, patients have seen their out-of-pocket costs for brand-name drugs increase by 50% between 2014 and 2022. Americans are footing the bill for PBMs' soaring profits. (Rep. Joanne Ferrary, 9/15)

I agree with the opening line of Tabitha Mueller’s Indy Explains: Are pharmacy benefit managers to blame for high drug prices – Nevadans do pay too much for prescription drugs. But I whole-heartedly disagree with Jared Whitley’s pro-pharmacy benefit manager (PBM) opinion piece. I haven’t experienced the health care system he outlined in my daily life. (Kjerstin West, 9/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ